Cancer Research Annual Meeting 2010 Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simmons, M. L.
Right arrow Articles by Aldape, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simmons, M. L.
Right arrow Articles by Aldape, K.
[Cancer Research 61, 1122-1128, February 1, 2001]
© 2001 American Association for Cancer Research

Regular Articles

Analysis of Complex Relationships between Age, p53, Epidermal Growth Factor Receptor, and Survival in Glioblastoma Patients1

Martha L. Simmons, Kathleen R. Lamborn, Michelle Takahashi, Pengchin Chen, Mark A. Israel, Mitchel S. Berger, Tony Godfrey, Janice Nigro, Michael Prados, Susan Chang, Fred G. Barker, II and Ken Aldape2

Departments of Pathology [M. L. S., M. T., J. N., K. A.], Epidemiology [P. C.], and Neurological Surgery [K. R. L., M. A. I., M. S. B., M. P., S. C.] and the Cancer Center [T. G.], University of California School of Medicine, San Francisco, California 94143-0506, and Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts 02114 [F. G. B.]

Glioblastoma multiforme (GBM) carries a dismal prognosis. However, a range of survival times exists, and parameters that define prognostic groups may help to optimize treatment. To identify such prognostic groups, we analyzed tumor tissue from 110 cases of newly diagnosed GBM from two clinical protocols. Similar to other studies, we found no association of epidermal growth factor receptor (EGFR) overexpression (as assessed by immunohistochemistry), p53 immunopositivity, or p53 mutation with survival in the entire sample. However, EGFR overexpression showed trends toward worse prognosis in patients younger than the median age, but better prognosis in patients older than the median age. This interaction of EGFR with age group was statistically significant and led us to focus our further analyses on the younger patients. In this group, a statistically significant association of EGFR overexpression with worse survival was identified in the p53-negative but not p53-positive tumors. We found a similar result after screening these cases for mutations in p53: EGFR overexpression was negatively associated with survival only in the p53 wild-type cases. To confirm this unexpected result, this finding was reproduced in a validation sample of an additional 42 tumors from younger patients on the same two clinical protocols. This complex relationship between EGFR and p53 in younger patients remained in a multivariate analysis that incorporated additional prognostic variables. The results suggest that analysis of prognostic markers in GBM is complex, and maximal information may require analysis of subgroups based on age and the status of specific markers such as p53. In addition, they suggest a specific group of patients on which to focus promising therapies targeting EGFR.




This article has been cited by other articles:


Home page
 Mol Cancer ResHome page
D. Palmieri, D. Fitzgerald, S. M. Shreeve, E. Hua, J. L. Bronder, R. J. Weil, S. Davis, A. M. Stark, M. J. Merino, R. Kurek, et al.
Analyses of Resected Human Brain Metastases of Breast Cancer Reveal the Association between Up-Regulation of Hexokinase 2 and Poor Prognosis
Mol. Cancer Res., September 1, 2009; 7(9): 1438 - 1445.
[Abstract] [Full Text] [PDF]

Home page
 Am J Clin PatholHome page
Y. Ruano, T. Ribalta, A. R. de Lope, Y. Campos-Martin, C. Fiano, E. Perez-Magan, J.-L. Hernandez-Moneo, M. Mollejo, and B. Melendez
Worse Outcome in Primary Glioblastoma Multiforme With Concurrent Epidermal Growth Factor Receptor and p53 Alteration
Am J Clin Pathol, February 1, 2009; 131(2): 257 - 263.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. M. McDonald, C. E. Pelloski, A. Ledoux, M. Sun, G. Raso, R. Komaki, I. I. Wistuba, B. N. Bekele, and K. Aldape
Elevated Phospho-S6 Expression Is Associated with Metastasis in Adenocarcinoma of the Lung
Clin. Cancer Res., December 1, 2008; 14(23): 7832 - 7837.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
W. P. Mason and J. G. Cairncross
Invited Article: The expanding impact of molecular biology on the diagnosis and treatment of gliomas
Neurology, July 29, 2008; 71(5): 365 - 373.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
H. Colman and K. Aldape
Molecular Predictors in Glioblastoma: Toward Personalized Therapy
Arch Neurol, July 1, 2008; 65(7): 877 - 883.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Aoki, T. Yokoyama, K. Fujiwara, A. M. Tari, R. Sawaya, D. Suki, K. R. Hess, K. D. Aldape, S. Kondo, R. Kumar, et al.
Phosphorylated Pak1 Level in the Cytoplasm Correlates with Shorter Survival Time in Patients with Glioblastoma
Clin. Cancer Res., November 15, 2007; 13(22): 6603 - 6609.
[Abstract] [Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
J. K. Wiencke, S. Zheng, N. Jelluma, T. Tihan, S. Vandenberg, T. Tamguney, R. Baumber, R. Parsons, K. R. Lamborn, M. S. Berger, et al.
Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma
Neuro-oncol, July 1, 2007; 9(3): 271 - 279.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. E. Pelloski, K. V. Ballman, A. F. Furth, L. Zhang, E. Lin, E. P. Sulman, K. Bhat, J. M. McDonald, W.K. A. Yung, H. Colman, et al.
Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma
J. Clin. Oncol., June 1, 2007; 25(16): 2288 - 2294.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Palmieri, J. L. Bronder, J. M. Herring, T. Yoneda, R. J. Weil, A. M. Stark, R. Kurek, E. Vega-Valle, L. Feigenbaum, D. Halverson, et al.
Her-2 Overexpression Increases the Metastatic Outgrowth of Breast Cancer Cells in the Brain
Cancer Res., May 1, 2007; 67(9): 4190 - 4198.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y.-J. Chen, V. Hakin-Smith, M. Teo, G. E. Xinarianos, D. A. Jellinek, T. Carroll, D. McDowell, M. R. MacFarlane, R. Boet, B. C. Baguley, et al.
Association of Mutant TP53 with Alternative Lengthening of Telomeres and Favorable Prognosis in Glioma.
Cancer Res., July 1, 2006; 66(13): 6473 - 6476.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. E. Pelloski, E Lin, L. Zhang, W.K. A. Yung, H. Colman, J.-L. Liu, S. Y. Woo, A. B. Heimberger, D. Suki, M. Prados, et al.
Prognostic Associations of Activated Mitogen-Activated Protein Kinase and Akt Pathways in Glioblastoma.
Clin. Cancer Res., July 1, 2006; 12(13): 3935 - 3941.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Wrensch, J. K. Wiencke, J. Wiemels, R. Miike, J. Patoka, M. Moghadassi, A. McMillan, K. T. Kelsey, K. Aldape, K. R. Lamborn, et al.
Serum IgE, Tumor Epidermal Growth Factor Receptor Expression, and Inherited Polymorphisms Associated with Glioma Survival.
Cancer Res., April 15, 2006; 66(8): 4531 - 4541.
[Abstract] [Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
M. Wrensch, T. Rice, R. Miike, A. McMillan, K. R. Lamborn, K. Aldape, and M. D. Prados
Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area
Neuro-oncol, January 1, 2006; 8(1): 12 - 26.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Aghi, P. Gaviani, J. W. Henson, T. T. Batchelor, D. N. Louis, and F. G. Barker II
Magnetic Resonance Imaging Characteristics Predict Epidermal Growth Factor Receptor Amplification Status in Glioblastoma
Clin. Cancer Res., December 15, 2005; 11(24): 8600 - 8605.
[Abstract] [Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
M. Wrensch, K. T. Kelsey, M. Liu, R. Miike, M. Moghadassi, J. D. Sison, K. Aldape, A. McMillan, J. Wiemels, and J. K. Wiencke
ERCC1 and ERCC2 polymorphisms and adult glioma
Neuro-oncol, October 1, 2005; 7(4): 495 - 507.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
S. A. Schwartz, R. J. Weil, R. C. Thompson, Y. Shyr, J. H. Moore, S. A. Toms, M. D. Johnson, and R. M. Caprioli
Proteomic-Based Prognosis of Brain Tumor Patients Using Direct-Tissue Matrix-Assisted Laser Desorption Ionization Mass Spectrometry
Cancer Res., September 1, 2005; 65(17): 7674 - 7681.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. K. Wiencke, K. Aldape, A. McMillan, J. Wiemels, M. Moghadassi, R. Miike, K. T. Kelsey, J. Patoka, J. Long, and M. Wrensch
Molecular Features of Adult Glioma Associated with Patient Race/Ethnicity, Age, and a Polymorphism in O6-Methylguanine-DNA-Methyltransferase
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1774 - 1783.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. E. Pelloski, A. Mahajan, M. Maor, E. L. Chang, S. Woo, M. Gilbert, H. Colman, H. Yang, A. Ledoux, H. Blair, et al.
YKL-40 Expression is Associated with Poorer Response to Radiation and Shorter Overall Survival in Glioblastoma
Clin. Cancer Res., May 1, 2005; 11(9): 3326 - 3334.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Liang, M. Diehn, N. Watson, A. W. Bollen, K. D. Aldape, M. K. Nicholas, K. R. Lamborn, M. S. Berger, D. Botstein, P. O. Brown, et al.
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme
PNAS, April 19, 2005; 102(16): 5814 - 5819.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Misra, M. Pellarin, J. Nigro, I. Smirnov, D. Moore, K. R. Lamborn, D. Pinkel, D. G. Albertson, and B. G. Feuerstein
Array Comparative Genomic Hybridization Identifies Genetic Subgroups in Grade 4 Human Astrocytoma
Clin. Cancer Res., April 15, 2005; 11(8): 2907 - 2918.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. M. Nigro, A. Misra, L. Zhang, I. Smirnov, H. Colman, C. Griffin, N. Ozburn, M. Chen, E. Pan, D. Koul, et al.
Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma
Cancer Res., March 1, 2005; 65(5): 1678 - 1686.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. B. Heimberger, R. Hlatky, D. Suki, D. Yang, J. Weinberg, M. Gilbert, R. Sawaya, and K. Aldape
Prognostic Effect of Epidermal Growth Factor Receptor and EGFRvIII in Glioblastoma Multiforme Patients
Clin. Cancer Res., February 15, 2005; 11(4): 1462 - 1466.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. B. Heimberger, E. C. McGary, D. Suki, M. Ruiz, H. Wang, G. N. Fuller, and M. Bar-Eli
Loss of the AP-2{alpha} Transcription Factor Is Associated with the Grade of Human Gliomas
Clin. Cancer Res., January 1, 2005; 11(1): 267 - 272.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. J. Marsit, M. Hasegawa, T. Hirao, D.-H. Kim, K. Aldape, P. W. Hinds, J. K. Wiencke, H. H. Nelson, and K. T. Kelsey
Loss of Heterozygosity of Chromosome 3p21 Is Associated with Mutant TP53 and Better Patient Survival in Non-Small-Cell Lung Cancer
Cancer Res., December 1, 2004; 64(23): 8702 - 8707.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
E. N. Eskandar, J. S. Loeffler, A. M. O'Neill, G. J. Hunter, and D. N. Louis
Case 33-2004 - A 34-Year-Old Man with a Seizure and a Frontal-Lobe Brain Lesion
N. Engl. J. Med., October 28, 2004; 351(18): 1875 - 1882.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Ohgaki, P. Dessen, B. Jourde, S. Horstmann, T. Nishikawa, P.-L. Di Patre, C. Burkhard, D. Schuler, N. M. Probst-Hensch, P. C. Maiorka, et al.
Genetic Pathways to Glioblastoma: A Population-Based Study
Cancer Res., October 1, 2004; 64(19): 6892 - 6899.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
R. N. Wiltshire, J. E. Herndon II, A. Lloyd, H. S. Friedman, D. D. Bigner, S. H. Bigner, and R. E. McLendon
Comparative Genomic Hybridization Analysis of Astrocytomas: Prognostic and Diagnostic Implications
J. Mol. Diagn., August 1, 2004; 6(3): 166 - 179.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
P. Leuraud, L. Taillandier, J. Medioni, L. Aguirre-Cruz, E. Criniere, Y. Marie, M. Kujas, J.-L. Golmard, A. Duprez, J.-Y. Delattre, et al.
Distinct Responses of Xenografted Gliomas to Different Alkylating Agents Are Related to Histology and Genetic Alterations
Cancer Res., July 1, 2004; 64(13): 4648 - 4653.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
Y. Watanabe, S. Kameoka, V. Gopalakrishnan, K. D. Aldape, Z. Z. Pan, F. F. Lang, and S. Majumder
Conversion of myoblasts to physiologically active neuronal phenotype
Genes & Dev., April 15, 2004; 18(8): 889 - 900.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. P. Steinbach, A. Klumpp, H. Wolburg, and M. Weller
Inhibition of Epidermal Growth Factor Receptor Signaling Protects Human Malignant Glioma Cells from Hypoxia-Induced Cell Death
Cancer Res., March 1, 2004; 64(5): 1575 - 1578.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. A. Bhowmick, Z. Zhuang, S. D. Wait, and R. J. Weil
A Functional Polymorphism in the EGF Gene Is Found with Increased Frequency in Glioblastoma Multiforme Patients and Is Associated with More Aggressive Disease
Cancer Res., February 15, 2004; 64(4): 1220 - 1223.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Shinojima, K. Tada, S. Shiraishi, T. Kamiryo, M. Kochi, H. Nakamura, K. Makino, H. Saya, H. Hirano, J.-i. Kuratsu, et al.
Prognostic Value of Epidermal Growth Factor Receptor in Patients with Glioblastoma Multiforme
Cancer Res., October 15, 2003; 63(20): 6962 - 6970.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. M. Backlund, B. R. Nilsson, H. M. Goike, E. E. Schmidt, L. Liu, K. Ichimura, and V. P. Collins
Short Postoperative Survival for Glioblastoma Patients with a Dysfunctional Rb1 Pathway in Combination with No Wild-type PTEN
Clin. Cancer Res., September 15, 2003; 9(11): 4151 - 4158.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A M Stark, P Witzel, R J Strege, H-H Hugo, and H M Mehdorn
p53, mdm2, EGFR, and msh2 expression in paired initial and recurrent glioblastoma multiforme
J. Neurol. Neurosurg. Psychiatry, June 1, 2003; 74(6): 779 - 783.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z.-y. Huang, Y. Wu, S. P. Burke, and D. H. Gutmann
The 43,000 Growth-associated Protein Functions as a Negative Growth Regulator in Glioma
Cancer Res., June 1, 2003; 63(11): 2933 - 2939.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. C. Burton, K. R. Lamborn, B. G. Feuerstein, M. Prados, J. Scott, P. Forsyth, S. Passe, R. B. Jenkins, and K. D. Aldape
Genetic Aberrations Defined by Comparative Genomic Hybridization Distinguish Long-Term from Typical Survivors of Glioblastoma
Cancer Res., November 1, 2002; 62(21): 6205 - 6210.
[Abstract] [Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
M. Wrensch, Y. Minn, T. Chew, M. Bondy, and M. S. Berger
Epidemiology of primary brain tumors: Current concepts and review of the literature
Neuro-oncol, October 1, 2002; 4(4): 278 - 299.
[Abstract] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Choe, J. K. Park, L. Jouben-Steele, T. J. Kremen, L. M. Liau, H. V. Vinters, T. F. Cloughesy, and P. S. Mischel
Active Matrix Metalloproteinase 9 Expression Is Associated with Primary Glioblastoma Subtype
Clin. Cancer Res., September 1, 2002; 8(9): 2894 - 2901.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. C. Burton, K. R. Lamborn, P. Forsyth, J. Scott, J. O'Campo, J. Uyehara-Lock, M. Prados, M. Berger, S. Passe, J. Uhm, et al.
Aberrant p53, mdm2, and Proliferation Differ in Glioblastomas from Long-Term Compared with Typical Survivors1
Clin. Cancer Res., January 1, 2002; 8(1): 180 - 187.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
J. S. Smith, I. Tachibana, S. M. Passe, B. K. Huntley, T. J. Borell, N. Iturria, J. R. O'Fallon, P. L. Schaefer, B. W. Scheithauer, C. D. James, et al.
PTEN Mutation, EGFR Amplification, and Outcome in Patients With Anaplastic Astrocytoma and Glioblastoma Multiforme
J Natl Cancer Inst, August 15, 2001; 93(16): 1246 - 1256.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.